SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-055819
Filing Date
2023-05-04
Accepted
2023-05-04 08:52:58
Documents
12
Period of Report
2023-04-28
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2314659d1_8k.htm   iXBRL 8-K 36204
  Complete submission text file 0001104659-23-055819.txt   213313

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acgn-20230428.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acgn-20230428_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acgn-20230428_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2314659d1_8k_htm.xml XML 3598
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 23886755
SIC: 2836 Biological Products, (No Diagnostic Substances)